Name the stages of labor, management of the first stage 2. Stages of preeclampsia. Management of eclampsia 3. Placenta praevia, diagnosis, management 4. Algorithm of diagnosis of cervical pathology 5. Uterine fibroid, diagnosis, management Give me answer like a human not ai ?

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Here are all five topics covered thoroughly:

1. Stages of Labor & Management of the First Stage

The Three Stages

First Stage — Cervical Dilation This starts when regular uterine contractions begin and ends when the cervix is fully dilated to 10 cm. It has two sub-phases:

Latent phase: Contractions are infrequent, irregular, and moderately uncomfortable. The cervix undergoes effacement and softening. This is the "preparatory" phase — slow progress is normal here.
Active phase: Begins around 3–4 cm dilation. Now dilation should progress at roughly 1.2 cm/hour in a first-time mother (nulliparous) and 1.5 cm/hour in someone who has delivered before (multiparous).

Average duration: ~12 hours for primigravidas, ~7 hours for multigravidas.

Second Stage — Expulsion Begins at full dilation, ends with delivery of the baby. Average 54 minutes for nulliparous and 20 minutes for multiparous women.

Third Stage — Placental From delivery of the baby to expulsion of the placenta and membranes. Normally under 10 minutes; active intervention is considered after 30 minutes. A retained placenta is one not expelled within 60 minutes.

Management of the First Stage

The goals are to monitor progress, detect complications early, support the mother, and ensure fetal well-being.

Monitoring:

Track the fetal heart rate continuously — normal is 120–160 bpm. Bradycardia (<110 bpm) or late decelerations (drops persisting >30 seconds after a contraction) signal fetal distress.
Maternal vitals: BP, HR, respiratory rate, temperature, SpO₂.
Vaginal examinations to assess cervical dilation, effacement, station, and position.

Partogram (Labor Chart): Progress in the active phase is plotted. If dilation rate falls below 1 cm/hour, dystocia (abnormal labor) should be considered and cause investigated (the 3 P's: Powers, Passage, Passenger).

General supportive care:

Encourage ambulation in the latent phase — upright positioning promotes descent.
Oral hydration or IV fluids as needed.
Emotional support and reassurance.
Analgesia — epidural analgesia is the most effective; nitrous oxide or opioids are alternatives.

True vs. False Labor (key clinical distinction):

Feature	True Labor	False Labor
Contractions	Regular, intervals shorten	Irregular, unchanged
Intensity	Gradually increases	Unchanged
Location	Back AND abdomen	Lower abdomen only
Effect of sedation	No relief	Usually relieved
Cervical dilation	Yes	No

If fetal distress is detected:

Position the mother in the left lateral decubitus (takes the uterus off the vena cava).
Give IV fluids.
Administer supplemental oxygen.
Call obstetric consultation urgently.

Sources: Tintinalli's Emergency Medicine; The Developing Human (Moore & Persaud); Rosen's Emergency Medicine

2. Stages of Preeclampsia & Management of Eclampsia

Classification of Hypertensive Disorders in Pregnancy

Hypertension complicates up to 8% of pregnancies. The spectrum goes:

Gestational Hypertension: New BP ≥140/90 mmHg after 20 weeks, without proteinuria or end-organ damage. Resolves postpartum.
Preeclampsia (Mild): Gestational hypertension PLUS proteinuria (>300 mg/24 hours). Managed with bed rest, monitoring, and waiting for fetal maturity. Delivery is definitive treatment; expectant management is standard before 34 weeks.
Severe Preeclampsia: BP ≥160/110 mmHg PLUS any of — severe headache, visual disturbances, epigastric/liver tenderness, pulmonary edema, oliguria. Hospitalize immediately. Magnesium sulfate for seizure prophylaxis.
HELLP Syndrome: The most dangerous preeclampsia variant — Hemolysis + Elevated Liver enzymes (ALT/AST >70 U/L) + Low Platelets (<100,000/mL). Treat like eclampsia with delivery as the definitive step.
Eclampsia: New-onset seizures in a preeclamptic patient. Unpredictable — can occur rapidly. This is the emergency endpoint of the spectrum.

Risk factors: Age <20 years, primigravida, twin/molar pregnancy, diabetes, obesity, family history, hypercholesterolemia.

Management of Eclampsia

The moment seizures happen, this becomes a life-threatening emergency. The management follows a clear sequence:

Step 1 — Stop the seizure:

Magnesium sulfate IV is the drug of choice — loading dose 4–6 g over 15–20 minutes, then maintenance 2 g/hour IV infusion.
Mechanism is not fully understood, but it is superior to other anticonvulsants and crucially maintains uteroplacental blood flow.
If seizures persist after full magnesium loading, add a second agent.

Step 2 — Watch for magnesium toxicity:

Loss of deep tendon reflexes → occurs at ~10 mg/dL
Respiratory depression → occurs at ~12 mg/dL
Antidote: Calcium gluconate 1 g IV slowly — reverses hypermagnesemia immediately.

Step 3 — Control blood pressure (after seizure control):

Target: reduce diastolic BP if >105 mmHg.
Hydralazine 5–10 mg IV push, repeat every 2–4 hours.
Labetalol 20 mg IV bolus, repeat every 10 minutes up to 300 mg total.

Step 4 — Labs to assess organ damage:

CBC + platelet count (thrombocytopenia?)
Liver function tests (hepatic involvement?)
BUN + creatinine (renal function?)
Coagulation profile
Blood glucose (exclude hypoglycemia as seizure cause)

Step 5 — Monitor urine output: Target >25 mL/hour. Avoid diuretics and hyperosmotic agents — the intravascular volume is already depleted.

Step 6 — CT head if: altered consciousness, seizures refractory to magnesium, lateralizing neurological signs, or concern for intracranial hemorrhage/venous thrombosis (which can also occur in pregnancy).

Step 7 — Deliver the baby. There is no cure for preeclampsia/eclampsia except delivery. Once the mother is stabilized, initiate steps toward delivery regardless of gestational age.

Source: Rosen's Emergency Medicine (Parkland Protocol)

3. Placenta Praevia — Diagnosis & Management

What It Is

Placenta praevia (previa) means the placenta has implanted over or near the internal cervical os. When the lower uterine segment stretches or the cervix begins to dilate, the anchored placental vessels tear — causing hemorrhage.

Types (by degree of coverage):

Complete (central) previa — placenta completely covers the os (~20% of cases, highest risk)
Partial previa
Marginal previa — placental edge reaches but doesn't cover the os
Low-lying placenta — near but not covering the os

Risk factors: Advanced maternal age, smoking, multiparity, prior cesarean section, previous uterine surgery, history of abortion, preterm labor.

Clinical Features

The classic presentation is painless, bright-red vaginal bleeding in the second or third trimester. This is the key feature that separates it from placental abruption (which typically has painful bleeding with a tense uterus).

~20% of cases have some uterine irritability, but it's usually minor.
Never perform a digital vaginal exam in a patient with painless antepartum bleeding until placenta praevia has been excluded by ultrasound — doing so can provoke catastrophic hemorrhage.
Speculum examination is acceptable but must be limited to gentle, partial insertion.
Rule of thumb: All patients with painless second-trimester vaginal bleeding should be assumed to have placenta praevia until proven otherwise.

Diagnosis

Ultrasound is the gold standard. It is safe, accurate, and should be done before any vaginal examination.

Transabdominal ultrasound first; empty the bladder before scanning (a full bladder can artificially push the posterior wall forward and falsely suggest previa).
Transvaginal ultrasound (TVS) is even more accurate for visualizing the relationship between the placental edge and the internal os — it is safe despite the diagnosis.
Many mid-trimester previas resolve by term as the lower uterine segment elongates and the placenta "migrates" away — this is called placental migration. Only total/central previa reliably persists.

Management

Immediate stabilization (ED/acute setting):

Two large-bore IV lines.
Fluid resuscitation — crystalloid initially.
Continuous fetal monitoring.
Baseline hemoglobin, blood type and crossmatch.
Coagulation studies: PT, PTT, platelet count, fibrinogen (normal pregnancy fibrinogen is 400–450 mg/dL; <300 mg/dL signals significant consumption).
Fresh-frozen plasma if coagulopathy is developing.
If Rh-negative and not yet received prophylaxis at 28 weeks — give Rh immune globulin 300 µg within 72 hours.
Urgent obstetric consultation and transfer to appropriate facility.

In-hospital management:

Fetal monitoring continued.
Blood transfusion if significant hemorrhage — whole blood or packed RBCs + FFP.
Delivery decision: Emergent cesarean section if there is uncontrolled hemorrhage, fetal distress, or the fetus is mature. In stable patients remote from term, conservative (expectant) management with hospitalization and pelvic rest.

Source: Rosen's Emergency Medicine; Creasy & Resnik's Maternal-Fetal Medicine

4. Algorithm for Diagnosis of Cervical Pathology

Cervical pathology diagnosis follows a stepwise, evidence-based algorithm — primarily guided by ASCCP (American Society for Colposcopy and Cervical Pathology) guidelines.

Step 1 — Cervical Cancer Screening (Cytology ± HPV)

Pap smear (cytology): Detects abnormal squamous or glandular cells. Results are reported using the Bethesda System:
- Normal / Negative for intraepithelial lesion
- ASC-US (atypical squamous cells of undetermined significance)
- LSIL (low-grade squamous intraepithelial lesion) → correlates with CIN 1
- HSIL (high-grade squamous intraepithelial lesion) → correlates with CIN 2–3
- AGC (atypical glandular cells)
- Carcinoma
HPV testing: Co-testing (Pap + HPV) is recommended for women ≥30 years. HPV-positive, cytology-negative women require further risk stratification.
HPV Genotyping: HPV 16 and 18 carry the highest cancer risk. Women who are HPV 16/18-positive should proceed directly to colposcopy; others can be followed with repeat testing in 12 months.

Step 2 — Colposcopy (for abnormal cytology or HPV results)

Colposcopy is the next step when screening is abnormal. The cervix is examined under magnification with acetic acid (shows acetowhite changes) and Lugol's iodine application. Abnormal-looking areas are biopsied.

Step 3 — Histologic Diagnosis (CIN grading)

CIN 1 (mild dysplasia): Often regresses spontaneously, especially in younger women. Observation is acceptable.
CIN 2 (moderate dysplasia): Borderline — management depends on age. Young/adolescent women may be observed for regression. Otherwise, treatment is recommended.
CIN 3 (severe dysplasia / carcinoma in situ): Treatment required — LEEP (loop electrosurgical excision procedure), cold-knife conization, or laser ablation.

Step 4 — Management by CIN Grade

Finding	Management
CIN 1	Observation with repeat cytology/colposcopy in 12 months
CIN 2 (adolescents/young women)	Observation or treatment — colposcopy + repeat cytology every 6 months for up to 2 years
CIN 2–3 (adults)	Excisional treatment (LEEP preferred)
CIN 3	Excision mandatory; conization if endocervical involvement
Microinvasive carcinoma	Cone biopsy with margin assessment; may need hysterectomy

Endocervical sampling (ECC) is added to colposcopy when the transformation zone is not fully visible or cytology shows AGC/HSIL.

Source: Pfenninger & Fowler's Procedures for Primary Care (ASCCP 2006 Consensus Guidelines); Goldman-Cecil Medicine

5. Uterine Fibroid (Leiomyoma) — Diagnosis & Management

What It Is

A uterine leiomyoma (fibroid, myoma) is a benign monoclonal smooth muscle tumor arising from the myometrium. It is the most common pelvic tumor in women. Growth is stimulated by estrogen and progesterone.

Types by location:

Submucosal — protrudes into the uterine cavity → most symptomatic, causes heavy bleeding and subfertility
Intramural — within the myometrial wall → most common type
Subserosal — projects outward from the uterine surface
Pedunculated — attached by a stalk (can be subserosal or submucosal)
Can also occur in the lower uterine segment or cervix.

Symptoms

Menorrhagia (heavy menstrual bleeding) — especially with submucosal fibroids
Pelvic pressure / bulk symptoms — from large fibroids
Dysmenorrhea — cramping pain similar to labor if a pedunculated submucosal fibroid is being expelled
Urinary symptoms — frequency/urgency from bladder compression
Subfertility / recurrent pregnancy loss
Acute pain from degeneration (loss of blood supply, often in pregnancy) or torsion of a pedunculated fibroid

Diagnosis

Clinical:

Bimanual exam: irregular, non-tender, solid uterine enlargement — an enlarged, lobulated uterus is characteristic.
Abdominal exam shows a palpable suprapubic mass in large fibroids.
With degeneration: localized tenderness, low-grade fever, mild tachycardia, leukocytosis.

Imaging:

Pelvic ultrasound is first-line — fibroids appear as spherical, well-defined, largely hypoechoic masses. It distinguishes uterine from adnexal pathology and can identify degeneration (heterogeneous echoes, internal liquefaction).
MRI pelvis is the most accurate modality — used when ultrasound is inconclusive, for surgical planning, or when uterine sarcoma needs to be excluded.
Hysteroscopy for submucosal fibroids — direct visualization of the uterine cavity.

Labs:

CBC (assess anemia from chronic blood loss)
Leukocytosis if degeneration is suspected

Differential diagnosis: Ovarian tumor, localized uterine contraction, uterine sarcoma, placental abruption (in pregnancy), duplicate uterine horn.

Management

Conservative (watchful waiting):

Asymptomatic fibroids in women not seeking fertility or with minimal symptoms — observe with periodic imaging. Fibroids typically regress after menopause.

Medical:

GnRH agonists (leuprolide, goserelin): Induce temporary medical menopause, shrink fibroids by 30–50%. Used preoperatively to reduce size or to temporize. Effect is lost once stopped.
Ulipristal acetate (selective progesterone receptor modulator): Controls bleeding and reduces size.
Tranexamic acid / NSAIDs / combined oral contraceptives: Control heavy bleeding symptomatically.
Levonorgestrel IUD: Reduces menorrhagia associated with intramural/subserosal fibroids (less effective for submucosal).

Surgical:

Myomectomy — surgical removal of fibroids while preserving the uterus; indicated in women who want to retain fertility. Can be performed hysteroscopically (submucosal), laparoscopically, or via open laparotomy depending on size, number, and location.
Hysterectomy — definitive treatment; for women with completed family or severe symptoms unresponsive to conservative measures.
Transcervical hysteroscopic resection — for submucosal pedunculated fibroids with pain and hemorrhage.

Interventional:

Uterine artery embolization (UAE) — radiological procedure that cuts off blood supply to fibroids, causing them to shrink. Effective for symptom control, preserves uterus but not always fertility.

Sources: Creasy & Resnik's Maternal-Fetal Medicine; Berek & Novak's Gynecology

These five topics are core obstetrics and gynecology — every answer above is based on standard textbook sources with current clinical practice. Let me know if you want any section expanded or turned into exam-style short answers.

This is a shared conversation. Sign in to Orris to start your own chat.